AboutBlogFDA EmployeeOver 40,000+ FDA inspection documents: 483s, EIRs, 483Rs

483 Valeant Pharmacueticals North America, Sep 2016

$179 - Available for instant download

FDA investigators audited the Valeant Pharmacueticals North America - Rochester , NY, United States facility and issued inspectional observation (via FDA 483) on 01 Sep 2016.

Product Details

  • Inspection end: 01 Sep 2016
  • Location: Rochester, United States
  • FEI: 3009443653
Valeant Pharmacueticals North America FDA inspection 483 Sep 2016